J&J aims to move up late-stage Covid-19 vaccine trial to Sept
New York: Global healthcare company Johnson & Johnson is planning to start a Phase-3 clinical trial of its Covid-19 vaccine ahead of its original schedule, potentially in late September, said a top executive of the company.
Johnson…
